Meeder Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Meeder Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-973	Closed	-$44K	–	1853
2017 Q4	$44K	Buy	973 +754	+344%	+$37.6K	﹤0.01%	723
2017 Q3	$10K	Buy	219 +169	+338%	+$5.76K	﹤0.01%	1092
2017 Q2	$1K	Buy	+50	New	+$1.23K	﹤0.01%	1608

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Meeder Asset Management's JUNO Position: Q1 2018 in Review

Meeder Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 973 shares — an estimated $44K sold.

Meeder Asset Management first reported a position in JUNO in Q2 2017 and held it in 3 quarters. The position peaked at $44K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Meeder Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Meeder Asset Management sold 973 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $44K.
Meeder Asset Management first reported a position in Juno Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
Meeder Asset Management's Juno Therapeutics, Inc. position peaked at $44K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.